Department of Pharmacology, School of Pharmacy, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, Japan.
Pharmacol Res. 2010 May;61(5):466-72. doi: 10.1016/j.phrs.2009.12.001. Epub 2009 Dec 17.
RhoA protein is involved in the Ca(2+) sensitization of bronchial smooth muscle (BSM) contraction, and an upregulation of RhoA in BSMs has been suggested in allergic bronchial asthma. However, the mechanism of upregulation of RhoA remains poorly understood. In the present study, the transcriptional regulation of human RhoA gene was investigated in cultured human BSM cells stimulated with IL-13 and TNF-alpha, both of which have an ability to upregulate RhoA protein. Luciferase-based assay showed that the RhoA promoter activity was augmented by both IL-13 and TNF-alpha. The deletion studies revealed a significant level of promoter activity between the 112 bp upstream and the transcription start site, which contains the STAT6 (78-70 bp upstream) and NF-kappaB (84-74 bp upstream) binding regions. The promoter activity was also decreased significantly by the mutations of these regions. Thus, the current study for the first time characterized the transcriptional regulation of the human RhoA gene. The findings also suggest that STAT6 and NF-kappaB are important for the upregulation of RhoA in human BSM induced by IL-13 and TNF-alpha, both of which are major cytokines in the pathogenesis of allergic bronchial asthma.
RhoA 蛋白参与了支气管平滑肌(BSM)收缩的 Ca(2+)敏化,并且在过敏性支气管哮喘中已经提出 BSMs 中的 RhoA 上调。然而,RhoA 上调的机制仍知之甚少。在本研究中,研究了在 IL-13 和 TNF-α刺激的培养人 BSM 细胞中人类 RhoA 基因的转录调节,这两者都具有上调 RhoA 蛋白的能力。基于荧光素酶的测定表明 RhoA 启动子活性被 IL-13 和 TNF-α 增强。缺失研究显示在转录起始位点上游 112 bp 与包含 STAT6(78-70 bp 上游)和 NF-kappaB(84-74 bp 上游)结合区之间存在显著的启动子活性。这些区域的突变也显著降低了启动子活性。因此,本研究首次描述了人类 RhoA 基因的转录调节。研究结果还表明,STAT6 和 NF-kappaB 对于 IL-13 和 TNF-α诱导的人 BSM 中 RhoA 的上调很重要,这两者都是过敏性支气管哮喘发病机制中的主要细胞因子。